Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Non Operating Income (2017 - 2025)

Historic Non Operating Income for Cardiff Oncology (CRDF) over the last 11 years, with Q3 2025 value amounting to $716000.0.

  • Cardiff Oncology's Non Operating Income fell 402.14% to $716000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 428.57%. This contributed to the annual value of $3.2 million for FY2024, which is 1891.21% down from last year.
  • As of Q3 2025, Cardiff Oncology's Non Operating Income stood at $716000.0, which was down 402.14% from $834000.0 recorded in Q2 2025.
  • Over the past 5 years, Cardiff Oncology's Non Operating Income peaked at $1.1 million during Q3 2023, and registered a low of -$253000.0 during Q2 2022.
  • Its 5-year average for Non Operating Income is $589368.4, with a median of $746000.0 in 2024.
  • Per our database at Business Quant, Cardiff Oncology's Non Operating Income soared by 886666.67% in 2021 and then plummeted by 29166.67% in 2022.
  • Over the past 5 years, Cardiff Oncology's Non Operating Income (Quarter) stood at $84000.0 in 2021, then skyrocketed by 727.38% to $695000.0 in 2022, then skyrocketed by 43.17% to $995000.0 in 2023, then fell by 21.11% to $785000.0 in 2024, then decreased by 8.79% to $716000.0 in 2025.
  • Its Non Operating Income was $716000.0 in Q3 2025, compared to $834000.0 in Q2 2025 and $948000.0 in Q1 2025.